# A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection

> **NCT00560599** · PHASE3 · COMPLETED · sponsor: **loren g miller** · enrollment: 350 (estimated)

## Conditions studied

- Methicillin Resistant Staphylococcus Aureus Skin Infections

## Interventions

- **DRUG:** mupirocin and chlorhexidine
- **BEHAVIORAL:** household cleaning and disinfection
- **DRUG:** mupirocin, chlorhexidine, & household cleaning/disinfection

## Key facts

- **NCT ID:** NCT00560599
- **Lead sponsor:** loren g miller
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2012-02
- **Final completion:** 2012-12
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2025-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00560599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00560599, "A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00560599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
